Ischemic heart disease Board decisions

The Board granted service connection for coronary artery disease, finding that the Veteran was exposed to Agent Orange during his service in Okinawa, Japan and that this exposure is presumed to have caused the condition.

The Board denied service connection for all claimed conditions as there was no evidence of a current disability or that any condition was related to the Veteran's active duty service.

The veteran withdrew the appeal for service connection for both pulmonary fibrosis and arteriosclerotic heart disease, valvular heart disease, myocardial infarction residuals, coronary artery bypass graft residuals atrial fibrillation, and abnormal right ventricular systolic function.

The appeal for service connection for a heart disability and stroke and its residuals was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied increased ratings for diabetes mellitus, diabetic retinopathy, ischemic heart disease, and depressive disorder, but granted special monthly compensation from May 23, 2017.

The Board remands the claim for a new medical opinion to address whether the Veteran's heart disability, including hypertension, is secondary to her service-connected psychiatric disorder.

The Board remands the claims for service connection for diabetes, a respiratory disorder, ischemic heart disease, and pancreatic cancer to conduct further development to verify the Veteran's alleged exposure to herbicide agents during service.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board denied the veteran's claims for service connection for valvular heart disease with orthostatic hypotension and allergic rhinitis (claimed as sinusitis) because the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury, event, or disease.

The Board denied service connection for benign prostatic hyperplasia and remanded the claims for left hand malignant melanoma, malignant melanoma of the face, heart disability, aortic aneurysm, and peripheral vascular disease of both lower extremities.

The Board dismissed the appeal for service connection for bilateral hearing loss as it had already been granted. The claims for heart condition, PTSD, and prostate cancer were remanded due to a duty to assist error.

The Board denied the Veteran's claims for increased ratings for hypertensive heart disease and hypertensive vascular disease, as the evidence did not support a higher rating.

The Board granted an effective date of March 30, 2022, for the awards of service connection for PTSD, irritable bowel syndrome, and arteriosclerotic heart disease.

The Board denied the veteran's claims for an earlier effective date, increased ratings, and TDIU, but granted a total disability rating based on individual unemployability beginning September 29, 2023.

The Board granted earlier effective dates for DEA, service connection for various scars, and CAD, all based on the Veteran's Intent to File (ITF) received on August 28, 2020.

The Board granted service connection for tinnitus and PTSD with anxiety and depression, but denied service connection for a heart disorder. All other claims were dismissed or remanded.

The Board remands the claims for service connection for chronic kidney disease, valvular heart disease with atrial fibrillation and heart failure preserved ejection fraction (claimed as coronary artery disease), hypertension, and rheumatoid arthritis to correct pre-decisional duty to assist errors.

The Board remands the claims for service connection for heart disease and liver disability, to include supraventricular arrhythmia and cirrhosis respectively, due to water contamination at Camp Lejeune.

The Board denied earlier effective dates, higher ratings for PTSD and CAD, a rating for RLE PN, TDIU, and DEA eligibility.

The Board granted an initial rating of 100 percent for coronary artery disease with bypass graft, as the Veteran's workload of 3.0 METs or less resulted in dyspnea and fatigue throughout the appeal period.